2020 annual meeting of the members and Coordinating Group of the European network of paediatric research at the EMA (Enpr-EMA)
Date:
28/09/2020
Location:
Virtual meeting
In 2020, Enpr-EMA held a meeting with the Coordinating Group and networks only instead of its regular annual workshop, considering the Agency’s business continuity plan related to COVID-19.
The European Commission provided feedback on the evaluation of the Paediatric and Orphan Regulations, as well as on the EU Pharmaceutical Strategy. Moreover, the meeting focused on the impact of COVID-19 in the paediatric population and facilitated a dialogue on overcoming the challenges caused by the pandemic on clinical trials in children, and learnings for the future.
-
List item
Agenda - 2020 annual meeting of the members and Coordinating Group of the European network of paediatric research at the EMA (Enpr-EMA) (PDF/249.48 KB)
First published: 16/12/2020
EMA/440708/2020 -
List item
Report from the 2020 annual meeting of the members and Coordinating Group of the European network of paediatric research at the EMA (Enpr-EMA) (PDF/365.49 KB)
First published: 16/12/2020
EMA/518319/2020 -
List item
Presentation - c4c Business Continuity Planning (M. Turner) (PDF/3.49 MB)
First published: 15/12/2020 -
List item
Presentation - c4c update for Enpr-EMA (M. Turner) (PDF/1.83 MB)
First published: 15/12/2020 -
List item
Presentation - Providing high-quality care remotely to patients with Rare Bone Diseases during COVID-19 pandemic (L. Sangiorgi) (PDF/1.55 MB)
First published: 15/12/2020 -
List item
Presentation - COVID-19 and Clinical Research in Canada (T. Lacaze) (PDF/296.41 KB)
First published: 15/12/2020 -
List item
Presentation - COVID-19 impact on paediatric clinical trials, and how to overcome the challenges. Can some new approaches be taken forward for future paediatric trials? Industry perspective (M. Dehlinger-Kremer, C. Ollivier) (PDF/2.33 MB)
First published: 15/12/2020 -
List item
Presentation - ERICA - ERN rare disease research coordination & support action (L. Sangiorgi) (PDF/504.26 KB)
First published: 15/12/2020 -
List item
Presentation - European Paediatric Translational Research Infrastructure (EPTRI) (D. Bonifazi) (PDF/3.38 MB)
First published: 15/12/2020 -
List item
Presentation - Evaluation of the legislation on medicines for children and rare diseases (F. D’Atri) (PDF/291.28 KB)
First published: 15/12/2020 -
List item
Presentation - Multi-Regional Clinical Trials (MRCT) Centerand its initiative on promoting global clinical research in children (D. Karres) (PDF/259.96 KB)
First published: 15/12/2020 -
List item
Presentation - Multisystem inflammatory syndrome in children and adolescents (temporally related to COVID-19) (L. Fregonese) (PDF/761.92 KB)
First published: 15/12/2020 -
List item
Presentation - Pharmaceutical strategy for Europe (A. Rodiadis) (PDF/858.52 KB)
First published: 15/12/2020 -
List item
Presentation - Preparedness for paediatric COVID vaccine trials (L. Fregonese) (PDF/780.62 KB)
First published: 15/12/2020 -
List item
Presentation - Enpr-EMA Annual Report 2019-2020 (P. Lepola) (PDF/282.76 KB)
First published: 15/12/2020 -
List item
Presentation - WG on clinical practice evidence in the labelling (S. de Wildt) (PDF/523.6 KB)
First published: 15/12/2020 -
List item
Presentation - Enpr-EMA Nurse - Coordinator Working Group (V.O’Mahony, P. Dicks) (PDF/214.75 KB)
First published: 15/12/2020